The mechanism of RDTs varies depending on the type of test. However, the general principle involves the detection of specific biomarkers related to the disease. For example, in LFAs, a sample (such as blood, saliva, or urine) is placed on a test strip. If the target antigen or antibody is present, it will bind to specific reagents on the strip, resulting in a visible line or color change.
